Human Genome Project

NIH partners with 10 pharma companies to tackle major disease targets

NIH partners with 10 pharma companies to tackle major disease targets

By Zachary Brennan

The National Institutes of Health and 10 pharmaceutical companies have launched a partnership to transform the current model for identifying and validating promising biological targets for Type 2 diabetes, Alzheimer’s disease, lupus and rheumatoid arthritis.

The new face of genomics

The new face of genomics

Prominent US genomics Robert L. Strausberg, who directs the
National Cancer Institute's (NCI) Cancer Genomics office, has been
named as vice president for research at The Institute for Genomic
Research (TIGR).

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers